シークレット カジノcal to Strengthen Research and Development Capabilities for its Health & Crop Sciences Business in North America

Apr. 15, 2016

シークレット カジノcal today announced that it will strengthen research and development capabilities in North America for its health and crop sciences business through expanding related facilities.

シークレット カジノcal's two of its Group companies, Valent U.S.A. Corporation (Valent U.S.A.), and Valent BioSciences Corporation (VBC), will be expanding their respective research and development facilities as outlined below. This move will enable シークレット カジノcal to accelerate research and development aimed at providing unique and innovative solutions based on the two technological disciplines of health and crop science, i.e. plant protection chemicals and biorationals.

シークレット カジノcal has research and development facilities for plant protection products in Japan, the U.S., and France, through which the Company is making incessant efforts to create new active ingredients. In addition to fortifying research and development functions in North America, the Company is currently working to build a new research and development base in Brazil, the world's largest market for plant protection products as well as a new synthesis research building in Japan. Going forward, the Company will continue to strengthen its research and development capabilities globally for its health and crop sciences business.

1. VBC relocating its research facility

VBC will relocate its existing research facility and build a new unit as Biorational Research Center in Illinois, U.S.A.
VBC was established in 2001 by シークレット カジノcal acquiring a certain business unit from Abbott Laboratories. Since then, the company has expanded its business to over 90 countries around the world, establishing its presence as the leading company in microbial insecticides, plant growth regulators and other products. The Biorational Research Center will be built near VBC's headquarters and expected to play a key role in better unifying activities of marketing and sales with research initiatives. シークレット カジノcal will position the Center as one of its global research and development base for its Health & Crop Sciences Sector. It will work closely with the Company's Health & Crop Sciences Research Laboratory in Japan, thereby further strengthening シークレット カジノcal's research and development on biorationals.

2. Valent U.S.A. building a new field testing station

Valent U.S.A. will build a new field testing station, the Mid-West Agricultural Research Center (MWARC), in the mid-western U.S. state of Illinois, in addition to its existing research center in the southern U.S. state of Mississippi. MWARC will accelerate product development as it allows field testing to be conducted in-house and in customers' agricultural environment. It will also facilitate advancing multifaceted and comprehensive research and development in areas that are at the forefront of emerging fields of research, such as pest control related to the rhizosphere (an area around roots of plants), nutrient absorption, and soil environment management.

Overview of VBC

Company name	Valent BioSciences Corporation
Location	Libertyville, Illinois, USA
Established	January 2000
President	Andrew Lee
Business areas	Research, development, production and sale of biorationals
Stock ownership	Valent U.S.A. Corporation - 100% (Valent U.S.A. Corporation is a wholly-owned subsidiary of シークレット カジノcal)

Overview of the Biorational Research Center

Name	Biorational Research Center
Location	Libertyville, Illinois, USA
Scale	5,600m2(capable of expanding as necessary)
Planned opening	Fiscal 2017

Overview of Valent U.S.A.

Company name	Valent U.S.A. Corporation
Location	Walnut Creek, California, USA
Established	April 1988
President	Andrew Lee
Business areas	Research, development, production and sale of agricultural chemicals
Stock ownership	シークレット カジノcal - 100%

Overview of MWARC

Name	Mid-West Agricultural Research Center
Location	Champagne, Illinois, USA
Scale	About 50 hectares (including greenhouses and office space)
Planned opening	Opening in fiscal 2016, phased expansion

Contact

Corporate Communications Dept.
27-1, Shinkawa 2-chome, Chuo-ku, Tokyo, 104-8260, Japan
TEL: +81-3-5543-5102 FAX: +81-3-5543-5901